Market open· · HKD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Total return, dividends included.
Where the price sits against its 50- and 200-day moving averages.
Makkler Fair Value, financial health score, analyst view, peers and MakklerAI.
Twist Bioscience has seen its assessed fair value move from US$105.30 to US$109.58, a modest reset that feeds into how analysts frame the stock’s price targets. The shift comes as research coverage splits between those pointing to higher peer comparables and AI driven drug discovery potential, and others who argue that recent gains and event driven enthusiasm already price in a lot of good news. In the sections that follow, you will see how these changing targets fit into the broader Twist...
Moderna will replace Warner Bros. Discovery in the Nasdaq-100 before markets open on Oct.9.
Neogen (NASDAQ:NEOG) shareholders approved all five proposals presented at the company’s 2026 annual meeting, including the election of three directors, advisory approval of executive compensation, and amendments to the company’s equity incentive and employee stock purchase plans. Chair of the Boar
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.